4//SEC Filing
BENET MIGUEL S 4
Accession 0000950170-25-031110
CIK 0001108109other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:02 PM ET
Size
18.5 KB
Accession
0000950170-25-031110
Insider Transaction Report
Form 4
BENET MIGUEL S
President and CMO
Transactions
- Tax Payment
Common Stock
2025-03-01$3.01/sh−10,515$31,650→ 47,635 total - Exercise/Conversion
Common Stock
2025-03-01+3,150→ 58,150 total - Exercise/Conversion
Performance Based Restricted
2025-03-01−3,150→ 11,850 totalExercise: $0.00→ Common Stock (3,150 underlying) - Disposition to Issuer
Performance Based Restricted
2025-03-01−11,850→ 0 totalExercise: $0.00→ Common Stock (11,850 underlying)
Holdings
- 30,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (30,000 underlying) - 15,000
Stock Options (Right to Buy)
Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (15,000 underlying) - 30,000
Stock Options (Right to Buy)
Exercise: $2.87From: 2025-03-01Exp: 2034-02-28→ Common Stock (30,000 underlying) - 30,000
Stock Options (Right to Buy)
Exercise: $6.15From: 2024-03-01Exp: 2033-02-28→ Common Stock (30,000 underlying) - 30,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850).
- [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
- [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
- [F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Documents
Issuer
COMMUNITY HEALTH SYSTEMS INC
CIK 0001108109
Entity typeother
Related Parties
1- filerCIK 0002044704
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:02 PM ET
- Size
- 18.5 KB